期刊文献+

组织S100Al mRNA和Snail mRNA检测在卵巢疾病中的应用 被引量:1

Application of detecting S100Al mRNA and Snail mRNA in tissues in the patients with ovarian diseases
下载PDF
导出
摘要 目的探讨组织钙结合蛋白S100Al m RNA和锌指转录因子Snail m RNA检测在卵巢疾病中的临床应用。方法选取2013年3月至2015年3月我院经病理确诊的卵巢病变组织标本共68例,通过RT-PCR技术检测卵巢良性囊腺瘤(良性肿瘤组)、交界性囊腺瘤(交界性肿瘤组)和卵巢囊腺癌(卵巢癌组)组织S100Al m RNA和Snail m RNA的表达,并测定各组血清癌胚抗原(CEA)、糖类抗原125(CA125)及人附睾分泌蛋白(HE4)水平,比较三组患者以上指标的变化。结果卵巢癌组组织S100Al m RNA和Snail m RNA的表达量与交界性肿瘤组和良性肿瘤组比较明显增高,差异均有显著统计学意义(P<0.01),交界性肿瘤组与良性肿瘤组比较明显增高,差异也有显著统计学意义(P<0.01);卵巢癌和交界性肿瘤组S100Al m RNA和Snail m RNA相对表达量具有相关性(r=0.629、0.571,P<0.01),组织S100Al m RNA和Snail m RNA分别与血清CA125及HE4呈现相关性(r=0.632、0.587,P<0.01;r=0.638、0.617,P<0.01)。结论联合检测组织S100Al m RNA和Snail m RNA在卵巢良性囊腺瘤、交界性囊腺瘤和卵巢囊腺癌病变组织中的表达,可增加卵巢囊腺癌的早期检出率,为上皮性卵巢疾病的鉴别诊断提供新的思路。 Objective To explore the application of detecting S100 Al m RNA and Snail m RNA in tissues in the patients with ovarian disease. Methods A total of tissue specimens from ovarian disease diagnosed by pathological section were selected from March 2013 to March 2015. The expression of S100 Al m RNA and Snail m RNA in tissues was detected in the ovarian benign cystic adenoma(benign tumor group), borderline cystic adenoma(borderline tumor group) and ovarian cystadenocarcinoma(ovarian cancer group) by RT-PCR technique, as well as the levels of serum carcino-embryonic antigen(CEA), carbohydrate antigen 125(CA125), and human epididymis secretory protein 4(HE4).The changes of the above indicators were compared among the three groups. Results The expression rates of S100 Al m RNA and Snail m RNA were significantly higher in ovarian cancer group than borderline tumor group and the benign tumor group(P<0.01), and also in borderline tumor group than benign tumor group(P<0.01). The relative expressions of S100 Al m RNA and Snail m RNA in tissues were correlated in the ovarian cancer group and the borderline tumor group(r=0.629, 0.571, P<0.01), and the two markers were correlated with the levels of serum CA-125 and HE4(r=0.632,0.587, P<0.01; r=0.638, 0.617, P<0.01). Conclusion Joint detection of expression of S100 Al m RNA and Snail m RNA in tissues in the ovarian benign cystic adenoma, borderline cystic adenoma and ovarian cystadenocarcinoma can increase the early detection rate of ovarian cystadenocarcinoma, providing a new thought for the differential diagnosis of the ovarian diseases.
作者 刘亚红 孙蓓
出处 《海南医学》 CAS 2016年第7期1051-1054,共4页 Hainan Medical Journal
关键词 卵巢良性囊腺瘤 卵巢交界性囊腺瘤 卵巢囊腺癌 S100Al M RNA SNAIL M RNA Ovarian benign cystic adenoma Borderline cystic adenoma Ovarian cystadenocarcinoma S100Al m RNA Snail m RNA
  • 相关文献

参考文献4

二级参考文献34

  • 1阳建福,张向阳,齐范.肾细胞癌组织中S100蛋白表达及与P53的关系[J].中南大学学报(医学版),2004,29(3):301-304. 被引量:2
  • 2黄文斌,陈洁宇,周晓军.KIT和RCC在肾嫌色细胞癌和透明细胞癌颗粒细胞亚型中鉴别诊断中的价值[J].临床与实验病理学杂志,2005,21(4):429-429. 被引量:13
  • 3殷涛,王春友,刘涛,赵刚,查运红.胰腺癌组织中Snail与E-钙黏素蛋白的表达及临床意义[J].中华医学杂志,2006,86(40):2821-2825. 被引量:14
  • 4Whitehouse C, Solomon E. Current status of the molecular character- ization of the ovarian cancer antigen CA125 and implications for its use in clinical screening[ J ]. Gynecol Oncol,2003 ;88 ( 1 ) : 152-157.
  • 5Oberaigner W, Minicozzi P, Bielska-Lasota Met al. Survival for ovar- ian cancer in Europe: the across-country variation did not shrink in the past decade[ J]. Acta Oncol,2012 ;51 (4) :441453.
  • 6Kirchhoff C. Molecular characterization of epididymal proteins [ J ]. Rev Reprod, 1998 ;3 ( 2 ) :86-95.
  • 7Galgano M T, Hampton G M, Frierson H F et al. Comprehensive a- nalysis of HE4 expression in normal and malignant human tissues [J]. Mad Pathol,2006;19(9) :847-853.
  • 8Hellstrom I, Raycraft J, Hayden-Ledbetter Met al. The HE4 ( WFDC2 ) protein is a biomarker for ovarian Carainoma [J]. Cancer Res,2003 ;63 ( 13 ) :3695-3700.
  • 9Havrilesky L J, Whitehead C M, Rubatt J Met al. Evaluation of bio- marker panels for early stage ovarian cancer detection andmonitoring for disease recurrence [ J ]. Gynecol Oncol, 2008 ; 110 (3) :374-382.
  • 10Cristina A, Filomena M C, Elci I Oet al . A comparison of CA125, HFA, risk ovarian malignancy algorithm (ROMA) , and risk malig- nancy index ( RMI ) for the classification of ovarian masses [ J ]. Clinics, 2012; 67(5) :437-441.

共引文献116

同被引文献5

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部